Acupuncture Chiropractic Med is categorized under Acupuncturists in Los Angeles, CA and active since 1995.
Acupuncture Chiropractic Med was established in 1995, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Acupuncturists business, which does work in the B2C market, and is classified as a Acupuncturists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Geve Irani, Owner at the company’s single location by writing to 12728 West Washington Boulevard, Los Angeles, California CA 90066 or by phoning (310) 823-6076. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Acupuncture Chiropractic Med |
| Contact Person: | Geve Irani, Owner |
| Address: | 12728 West Washington Boulevard, Los Angeles, California 90066 |
| Phone Number: | (310) 823-6076 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Acupuncturists |
| SIC Code: | 8049 |
| NAICS Code: | 6214930 |
| Share This Business: |
Acupuncture Chiropractic Med was started in 1995 to provide professional Acupuncturists under the SIC code 8049 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Geve Irani, Owner for inquiries that concern Acupuncture Chiropractic Med by calling the company number (310) 823-6076, as your correspondence is most welcome. Additionally, the physical location of the single location of Acupuncture Chiropractic Med can be found at the coordinates 33.99657,-118.43532 as well as the street address 12728 West Washington Boulevard in Los Angeles, California 90066.
For its online presence, you may visit Acupuncture Chiropractic Med’s website at and engage with its social media outlets through on Twitter and on Facebook.